The Job position is funded the ANR-funded ImSynPark project (2026-2029).
The proposed project aims to target the alpha-synuclein protein using CEST imaging: towards a new biomarker for Parkinson’s disease.
Why work with us ?
– Be part of an innovative research project on a neurodegenerative disease
– Work with a collaborative group based in Rennes, Lille, Angers and Bordeaux
– Live in Rennes, a dynamic city with high quality of life and direct access to the sea and Paris.
PhD with expertise in quantitative MRI, data acquisition and analysis
Experience in CEST-MRI would be appreciated
33-35 k€/year
Research unit : LTSI Inserm 1099 – Rennes, France –
